Research Papers:
Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases
Metrics: PDF 1682 views | HTML 2292 views | ?
Abstract
Zhiyu Wang1,*, Xiaoting Wen1,*, Yaohong Lu1, Yang Yao1, Hui Zhao1
1Department of Internal Oncology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China
*These authors contributed equally to this work
Correspondence to:
Hui Zhao, e-mail: [email protected]
Keywords: machine learning, skeletal-related events, bone metastases, decision tree, support vector machine
Received: October 11, 2015 Accepted: January 24, 2016 Published: February 09, 2016
ABSTRACT
The aim of the bone metastases (BM) treatment is to prevent the occurrence of skeletal-related events (SREs). In clinical, physicians could only predict the occurrence of SREs by subjective experience. Machine learning (ML) could be used as predictive models in the medical field. But there is no published research using ML to predict SREs in cancer patients with BM. The purpose of this study was to assess the associations of clinical variables with the occurrence of SREs and to subsequently develop prediction models to help identify SREs risk groups.
We analyzed 1143 cancer patients with BM. We used the statistical package of SPSS and SPSS Modeler for data analysis and the development of the prediction model. We compared the performance of logistic regression (LR), decision tree (DT) and support vector machine(SVM). The results suggested that Visual Analog Scale (VAS) scale was a key factor to SREs in LR, DT and SVM model. Modifiable factors such as Frankel classification, Mirels score, Ca, aminoterminal propeptide of type I collagen (PINP) and bone-specific alkaline phosphatase (BALP) were identified. We found that the result of applying LR, DT and SVM classification accuracy was 79.2%, 85.8% and 88.2%, with 9, 4 and 8 variables, respectively.
In conclusion, DT and SVM achieved higher accuracies with smaller number of variables than the number of variables used in LR. ML techniques can be used to build model to predict SREs in cancer patients with BM.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7278